{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:27:48Z","timestamp":1791149268812,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T00:00:00Z","timestamp":1255392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T00:00:00Z","timestamp":1255392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/ijo.2009.204","type":"journal-article","created":{"date-parts":[[2009,10,13]],"date-time":"2009-10-13T09:53:25Z","timestamp":1255427605000},"page":"118-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study"],"prefix":"10.1038","volume":"34","author":[{"given":"G","family":"Luc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Empana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Juhan-Vague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Arveiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ferrieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Kee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Machez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ducimetiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,10,13]]},"reference":[{"key":"BFijo2009204_CR1","first-page":"429","volume":"149","author":"GA Bray","year":"1988","unstructured":"Bray GA, Gray DS . Obesity. Part I\u2014Pathogenesis. West J Med 1988; 149: 429\u2013441.","journal-title":"West J Med"},{"key":"BFijo2009204_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg AH, Scherer PE . Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939\u2013949.","journal-title":"Circ Res"},{"key":"BFijo2009204_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-8703(03)00181-9","volume":"146","author":"LS Piegas","year":"2003","unstructured":"Piegas LS, Avezum A, Pereira JC, Neto JM, Hoepfner C, Farran JA et al. Risk factors for myocardial infarction in Brazil. Am Heart J 2003; 146: 331\u2013338.","journal-title":"Am Heart J"},{"key":"BFijo2009204_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1093\/oxfordjournals.aje.a008892","volume":"144","author":"SP Walker","year":"1996","unstructured":"Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC . Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol 1996; 144: 1143\u20131150.","journal-title":"Am J Epidemiol"},{"key":"BFijo2009204_CR5","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1161\/CIRCULATIONAHA.107.739714","volume":"117","author":"C Zhang","year":"2008","unstructured":"Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB . Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008; 117: 1658\u20131667.","journal-title":"Circulation"},{"key":"BFijo2009204_CR6","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1210\/jc.2004-0395","volume":"89","author":"EE Kershaw","year":"2004","unstructured":"Kershaw EE, Flier JS . Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89: 2548\u20132556.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1079\/BJN20041213","volume":"92","author":"P Trayhurn","year":"2004","unstructured":"Trayhurn P, Wood IS . Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347\u2013355.","journal-title":"Br J Nutr"},{"key":"BFijo2009204_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","volume":"21","author":"BL Wajchenberg","year":"2000","unstructured":"Wajchenberg BL . Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697\u2013738.","journal-title":"Endocr Rev"},{"key":"BFijo2009204_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1161\/hq0102.101552","volume":"22","author":"D Bastelica","year":"2002","unstructured":"Bastelica D, Morange P, Berthet B, Borghi H, Lacroix O, Grino M et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002; 22: 173\u2013178.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFijo2009204_CR10","first-page":"133","volume":"10","author":"W de Jager","year":"2003","unstructured":"de Jager W, te VH, Prakken BJ, Kuis W, Rijkers GT . Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003; 10: 133\u2013139.","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFijo2009204_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jpba.2004.05.024","volume":"36","author":"CA Ray","year":"2005","unstructured":"Ray CA, Bowsher RR, Smith WC, Devanarayan V, Willey MB, Brandt JT et al. Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum. J Pharm Biomed Anal 2005; 36: 1037\u20131044.","journal-title":"J Pharm Biomed Anal"},{"key":"BFijo2009204_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1093\/qjmed\/91.10.667","volume":"91","author":"JW Yarnell","year":"1998","unstructured":"Yarnell JW . The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland Prospective Epidemiological Study of Myocardial Infarction. QJM 1998; 91: 667\u2013676.","journal-title":"QJM"},{"key":"BFijo2009204_CR13","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","volume":"90","author":"H Tunstall-Pedoe","year":"1994","unstructured":"Tunstall-Pedoe H, Kuulasma K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A . Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Circulation 1994; 90: 583\u2013612.","journal-title":"Circulation"},{"key":"BFijo2009204_CR14","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/ije\/30.5.1057","volume":"30","author":"P Ducimetiere","year":"2001","unstructured":"Ducimetiere P, Ruidavets JB, Montaye M, Haas B, Yarnell J . Five-year incidence of angina pectoris and other forms of coronary heart disease in healthy men aged 50\u201359 in France and Northern Ireland: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study. Int J Epidemiol 2001; 30: 1057\u20131062.","journal-title":"Int J Epidemiol"},{"key":"BFijo2009204_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1161\/CIRCULATIONAHA.106.618918","volume":"114","author":"N Sattar","year":"2006","unstructured":"Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006; 114: 623\u2013629.","journal-title":"Circulation"},{"key":"BFijo2009204_CR16","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1161\/01.ATV.0000153090.21990.8c","volume":"25","author":"RS Lindsay","year":"2005","unstructured":"Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y et al. Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 2005; 25: e15\u2013e16.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFijo2009204_CR17","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/eurheartj\/ehl153","volume":"27","author":"E Cavusoglu","year":"2006","unstructured":"Cavusoglu E, Ruwende C, Chopra V, Yanamadala S, Eng C, Clark LT et al. Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J 2006; 27: 2300\u20132309.","journal-title":"Eur Heart J"},{"key":"BFijo2009204_CR18","doi-asserted-by":"publisher","first-page":"5677","DOI":"10.1210\/jc.2005-0825","volume":"90","author":"DA Lawlor","year":"2005","unstructured":"Lawlor DA, Davey SG, Ebrahim S, Thompson C, Sattar N . Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005; 90: 5677\u20135683.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1681\/ASN.V131134","volume":"13","author":"C Zoccali","year":"2002","unstructured":"Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13: 134\u2013141.","journal-title":"J Am Soc Nephrol"},{"key":"BFijo2009204_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00125-004-1597-y","volume":"48","author":"T Costacou","year":"2005","unstructured":"Costacou T, Zgibor JC, Evans RW, Otvos J, Lopes-Virella MF, Tracy RP et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 2005; 48: 41\u201348.","journal-title":"Diabetologia"},{"key":"BFijo2009204_CR21","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jacc.2004.07.050","volume":"44","author":"R Wolk","year":"2004","unstructured":"Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK . Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004; 44: 1819\u20131824.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2009204_CR22","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1210\/jc.2008-0640","volume":"93","author":"JR Kizer","year":"2008","unstructured":"Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS . Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 2008; 93: 3357\u20133364.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/eurheartj\/ehn009","volume":"29","author":"R Schnabel","year":"2008","unstructured":"Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008; 29: 649\u2013657.","journal-title":"Eur Heart J"},{"key":"BFijo2009204_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1210\/jc.2006-1067","volume":"92","author":"J Frystyk","year":"2007","unstructured":"Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B . Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007; 92: 571\u2013576.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR25","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1093\/eurheartj\/ehn135","volume":"29","author":"M von Eynatten","year":"2008","unstructured":"von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D et al. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J 2008; 29: 1307\u20131315.","journal-title":"Eur Heart J"},{"key":"BFijo2009204_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/aje\/kwk001","volume":"165","author":"GA Laughlin","year":"2007","unstructured":"Laughlin GA, Barrett-Connor E, May S, Langenberg C . Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol 2007; 165: 164\u2013174.","journal-title":"Am J Epidemiol"},{"key":"BFijo2009204_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.jacc.2006.06.053","volume":"48","author":"W Koenig","year":"2006","unstructured":"Koenig W, Khuseyinova N, Baumert J, Meisinger C, L\u00f6wel H . Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006; 48: 1369\u20131377.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2009204_CR28","doi-asserted-by":"publisher","first-page":"5044","DOI":"10.1210\/jc.2006-0107","volume":"91","author":"AM Kanaya","year":"2006","unstructured":"Kanaya AM, Wassel FC, Vittinghoff E, Havel PJ, Cesari M, Nicklas B et al. Serum adiponectin and coronary heart disease risk in older Black and White Americans. J Clin Endocrinol Metab 2006; 91: 5044\u20135050.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR29","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"UB Pajvani","year":"2004","unstructured":"Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152\u201312162.","journal-title":"J Biol Chem"},{"key":"BFijo2009204_CR30","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1161\/01.RES.0000119921.86460.37","volume":"94","author":"H Kobayashi","year":"2004","unstructured":"Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M, Abe Y et al. Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin. Circ Res 2004; 94: e27\u2013e31.","journal-title":"Circ Res"},{"key":"BFijo2009204_CR31","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1210\/jc.2007-2603","volume":"93","author":"N Sattar","year":"2008","unstructured":"Sattar N, Watt P, Cherry L, Ebrahim S, Davey Smith G, Lawlor DA . High molecular weight adiponectin is not associated with incident coronary heart disease in older women: a nested prospective case-control study. J Clin Endocrinol Metab 2008; 93: 1846\u20131849.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.amjcard.2007.03.062","volume":"100","author":"T Inoue","year":"2007","unstructured":"Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 2007; 100: 569\u2013574.","journal-title":"Am J Cardiol"},{"key":"BFijo2009204_CR33","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1161\/01.ATV.21.4.611","volume":"21","author":"AR Folsom","year":"2001","unstructured":"Folsom AR, Aleksic N, Park E, Salomaa V, Juneja H, Wu KK . Prospective study of fibrinolytic factors and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2001; 21: 611\u2013617.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFijo2009204_CR34","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1161\/01.CIR.98.21.2241","volume":"98","author":"AM Thogersen","year":"1998","unstructured":"Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation 1998; 98: 2241\u20132247.","journal-title":"Circulation"},{"key":"BFijo2009204_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-0037-1614231","volume":"79","author":"GD Lowe","year":"1998","unstructured":"Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC . Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost 1998; 79: 129\u2013133.","journal-title":"Thromb Haemost"},{"key":"BFijo2009204_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/01.ATV.19.3.493","volume":"19","author":"M Cushman","year":"1999","unstructured":"Cushman M, Lemaitre RN, Kuller LH, Psaty BM, Macy EM, Sharrett AR et al. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 493\u2013498.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFijo2009204_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","volume":"55","author":"C Lara-Castro","year":"2006","unstructured":"Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT . Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006; 55: 249\u2013259.","journal-title":"Diabetes"},{"key":"BFijo2009204_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.atherosclerosis.2008.04.011","volume":"202","author":"L Tian","year":"2009","unstructured":"Tian L, Luo N, Klein RL, Chung BH, Garvey WT, Fu Y et al. Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 2009; 202: 152\u2013161.","journal-title":"Atherosclerosis"},{"key":"BFijo2009204_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0140-6736(03)12255-6","volume":"361","author":"J Spranger","year":"2003","unstructured":"Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226\u2013228.","journal-title":"Lancet"},{"key":"BFijo2009204_CR40","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.metabol.2008.02.019","volume":"57","author":"JN Fain","year":"2008","unstructured":"Fain JN, Buehrer B, Bahouth SW, Tichansky DS, Madan AK . Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue. Metabolism 2008; 57: 1005\u20131015.","journal-title":"Metabolism"},{"key":"BFijo2009204_CR41","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1161\/ATVB.17v07.1239","volume":"17","author":"K Cianflone","year":"1997","unstructured":"Cianflone K, Zhang XJ, Genest Jr J, Sniderman A . Plasma acylation-stimulating protein in coronary artery disease. Arterioscler Thromb Vasc Biol 1997; 17: 1239\u20131244.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFijo2009204_CR42","first-page":"213","volume":"18","author":"A Napolitano","year":"1994","unstructured":"Napolitano A, Lowell BB, Damm D, Leibel RL, Ravussin E, Jimerson DC et al. Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 1994; 18: 213\u2013218.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BFijo2009204_CR43","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1038\/oby.2005.215","volume":"13","author":"T Pischon","year":"2005","unstructured":"Pischon T, Bamberger CM, Kratzsch J, Zyriax BC, Algenstaedt P, Boeing H et al. Association of plasma resistin levels with coronary heart disease in women. Obes Res 2005; 13: 1764\u20131771.","journal-title":"Obes Res"},{"key":"BFijo2009204_CR44","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jacc.2005.04.022","volume":"46","author":"R Ohmori","year":"2005","unstructured":"Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005; 46: 379\u2013380.","journal-title":"J Am Coll Cardiol"},{"key":"BFijo2009204_CR45","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.CIR.0000155620.10387.43","volume":"111","author":"MP Reilly","year":"2005","unstructured":"Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ . Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932\u2013939.","journal-title":"Circulation"},{"key":"BFijo2009204_CR46","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/jc.2007-2735","volume":"93","author":"C Weikert","year":"2008","unstructured":"Weikert C, Westphal S, Berger K, Dierkes J, M\u00f6hlig M, Spranger J et al. Plasma resistin levels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 2008; 93: 2647\u20132653.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/CS20050078","volume":"109","author":"CM Kusminski","year":"2005","unstructured":"Kusminski CM, McTernan PG, Kumar S . Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond) 2005; 109: 243\u2013256.","journal-title":"Clin Sci (Lond)"},{"key":"BFijo2009204_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","volume":"300","author":"L Patel","year":"2003","unstructured":"Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472\u2013476.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFijo2009204_CR49","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1210\/jcem.87.5.8627","volume":"87","author":"PG McTernan","year":"2002","unstructured":"McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN et al. Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002; 87: 2407.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFijo2009204_CR50","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/sj.ijo.0803037","volume":"29","author":"S Bo","year":"2005","unstructured":"Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M et al. Relationships between human serum resistin, inflammatory markers and insulin resistance. Int J Obes (Lond) 2005; 29: 1315\u20131320.","journal-title":"Int J Obes (Lond)"},{"key":"BFijo2009204_CR51","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2337\/diacare.21.5.782","volume":"21","author":"C Couillard","year":"1998","unstructured":"Couillard C, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S et al. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 1998; 21: 782\u2013786.","journal-title":"Diabetes Care"},{"key":"BFijo2009204_CR52","first-page":"581","volume":"29","author":"K Piestrzeniewicz","year":"2008","unstructured":"Piestrzeniewicz K, Luczak K, Goch JH . Value of blood adipose tissue hormones concentration\u2014adiponectin, resistin and leptin in the prediction of major adverse cardiac events (MACE) in 1-year follow-up after primary percutaneous coronary intervention in ST-segment el. Neuro Endocrinol Lett. 2008; 29: 581\u2013588.","journal-title":"Neuro Endocrinol Lett."},{"key":"BFijo2009204_CR53","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/oby.2007.202","volume":"15","author":"DA Lawlor","year":"2007","unstructured":"Lawlor DA, Smith GD, Kelly A, Sattar N, Ebrahim S . Leptin and coronary heart disease risk: prospective case control study of British women. Obesity (Silver Spring) 2007; 15: 1694\u20131701.","journal-title":"Obesity (Silver Spring)"},{"key":"BFijo2009204_CR54","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1161\/hc5001.101061","volume":"104","author":"AM Wallace","year":"2001","unstructured":"Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104: 3052\u20133056.","journal-title":"Circulation"},{"key":"BFijo2009204_CR55","doi-asserted-by":"publisher","first-page":"2883","DOI":"10.2337\/diacare.26.10.2883","volume":"26","author":"L Piemonti","year":"2003","unstructured":"Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003; 26: 2883\u20132889.","journal-title":"Diabetes Care"},{"key":"BFijo2009204_CR56","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/(SICI)1096-9136(199705)14:5<376::AID-DIA370>3.0.CO;2-9","volume":"14","author":"V Mohamed-Ali","year":"1997","unstructured":"Mohamed-Ali V, Pinkney JH, Panahloo A, Goodrick S, Coppack SW, Yudkin JS et al. Relationships between plasma leptin and insulin concentrations, but not insulin resistance, in non-insulin-dependent (type 2) diabetes mellitus. Diabet Med 1997; 14: 376\u2013380.","journal-title":"Diabet Med"},{"key":"BFijo2009204_CR57","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","volume":"112","author":"A Smith","year":"2005","unstructured":"Smith A, Patterson C, Yarnell J, Rumley A, Ben-Shlomo Y, Lowe G . Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study. Circulation 2005; 112: 3080\u20133087.","journal-title":"Circulation"},{"key":"BFijo2009204_CR58","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1161\/01.CIR.94.9.2057","volume":"94","author":"I Juhan-Vague","year":"1996","unstructured":"Juhan-Vague I, Pyke SD, Alessi MC, Jespersen J, Haverkate F, Thompson SG . Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation 1996; 94: 2057\u20132063.","journal-title":"Circulation"},{"key":"BFijo2009204_CR59","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMoa032804","volume":"350","author":"J Danesh","year":"2004","unstructured":"Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387\u20131397.","journal-title":"N Engl J Med"},{"key":"BFijo2009204_CR60","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1371\/journal.pmed.0050078","volume":"5","author":"J Danesh","year":"2008","unstructured":"Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB et al. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med 2008; 5: e78.","journal-title":"PLoS Med"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ijo2009204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2009204","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ijo2009204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T06:03:45Z","timestamp":1729058625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ijo2009204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,13]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFijo2009204"],"URL":"https:\/\/doi.org\/10.1038\/ijo.2009.204","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,13]]},"assertion":[{"value":"14 January 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}